Abstract:Oxidative phosphorylation is regulated by mitochondrial calcium (Ca 2+ ) in health and disease. In physiological states, Ca 2+ enters via the mitochondrial Ca 2+ uniporter and rapidly enhances NADH and ATP production. However, maintaining Ca 2+ homeostasis is critical: insufficient Ca 2+ impairs stress adaptation, while Ca 2+ overload can trigger cell death. In this review, we delve into recent insights further defining the relationship between mitochondrial Ca 2+ dynamics and oxidative phosphorylation. Our focus is on how such regulation affects cardiac function in health and disease, including heart failure, ischemia-reperfusion, arrhythmias, catecholaminergic polymorphic ventricular tachycardia, mitochondrial cardiomyopathies, Barth syndrome, and Friedreich's ataxia. Several themes emerge from recent data. First, mitochondrial Ca 2+ regulation is critical for fuel substrate selection, metabolite import, and matching of ATP supply to demand. Second, mitochondrial Ca 2+ regulates both the production and response to reactive oxygen species (ROS), and the balance between its pro- and antioxidant effects is key to how it contributes to physiological and pathological states. Third, Ca 2+ exerts localized effects on the electron transport chain (ETC), not through traditional allosteric mechanisms, but rather indirectly. These effects hinge on specific transporters, such as the uniporter or the Na + -Ca 2+ exchanger and may not be noticeable acutely, contributing differently to phenotypes depending on whether Ca 2+ transporters are acutely or chronically modified. Perturbations in these novel relationships during disease states may either serve as compensatory mechanisms or exacerbate impairments in oxidative phosphorylation. Consequently, targeting mitochondrial Ca 2+ holds promise as a therapeutic strategy for a variety of cardiac diseases characterized by contractile failure or arrhythmias.

Mitochondrial Ca2+ in Heart Failure: Not Enough or Too Much?

Mitochondria-associated membrane-modulated Ca<SUP>2+</SUP> transfer: A potential treatment target in cardiac ischemia reperfusion injury and heart failure

Mitochondrial Ca2+ regulation in the etiology of heart failure: physiological and pathophysiological implications

Mitochondrial calcium regulation of cardiac metabolism in health and disease

Theoretical Investigation Of The Mechanism Of Heart Failure Using A Canine Ventricular Cell Model: Especially The Role Of Up-Regulated Camkii And Sr Ca2+ Leak

Mitochondrial Calcium Overload Plays a Causal Role in Oxidative Stress in the Failing Heart

A Mitochondrial Basis for Heart Failure Progression

Mitochondrial Ca2+ Homeostasis: Emerging Roles and Clinical Significance in Cardiac Remodeling

Mitochondrial ATPase and High-Energy Phosphates in Failing Hearts.

Mitochondrial Dysfunction in Heart Failure and Its Therapeutic Implications

Regulation of the human cardiac mitochondrial Ca2+ uptake by 2 different voltage-gated Ca2+ channels

Beyond the TCA cycle: new insights into mitochondrial calcium regulation of oxidative phosphorylation

Mitochondrial dysfunction and mitochondrial therapies in heart failure

Novel insights into the involvement of mitochondrial fission/fusion in heart failure: From molecular mechanisms to targeted therapies

From Pathophysiological Mechanisms to Therapeutic Opportunities

Mitochondrial Ca2+ uptake in skeletal muscle health and disease

Mitochondrial dynamics and cell death in heart failure

Abnormal phosphorylation / dephosphorylation and Ca2+ dysfunction in heart failure

Mitochondrial Ca2+ Uniporter-Dependent Energetic Dysfunction Drives Hypertrophy in Heart Failure

Molecular regulation of mitochondrial dynamics in cardiac disease

Mitochondrial calcium in cardiac ischemia/reperfusion injury and cardioprotection